The effect of the reparative action drug in treatment of pediatric duodenal ulcer

Dudnyk, V. M.; Buhlova, N. O.; Morozova, I. V.; Kukuruza, T. Y.

dc.contributor.author	Dudnyk, V. M.	en
dc.contributor.author	Buhlova, N. O.	en
dc.contributor.author	Morozova, I. V.	en
dc.contributor.author	Kukuruza, T. Y.	en
dc.date.accessioned	2023-02-20T10:01:17Z
dc.date.available	2023-02-20T10:01:17Z
dc.date.issued	2022
dc.identifier.citation	The effect of the reparative action drug in treatment of pediatric duodenal ulcer / V. M. Dudnyk, N. O. Buhlova, I. V. Morozova, T. Y. Kukuruza // Perinatology and Pediatrics. - 2022. - № 4 (92). - P. 33-36.	uk_UA
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/6044
dc.description.abstract	Digestive tract diseases occupy one of the first places in the structure of childhood pathology, including duodenal ulcers (DU), the development of which in 70–100% of cases is associated with H.pylori infection. It is found that the important role in the development of inflammatory process in digestive tract have toll-like receptors 4 (TLR4), due to reactiveness to H.pylori. It is proved that growth factors, in particular epidermal growth factor (EGF), are able to influence on the healing processes in the mucous membrane. It is advisable to include drugs of reparative action in complex treatment of pediatric DU.	en
dc.language.iso	en	en
dc.subject	children	en
dc.subject	duodenal ulcer	en
dc.subject	drug of reparative function	en
dc.subject	Helicobacter pylori
dc.title	The effect of the reparative action drug in treatment of pediatric duodenal ulcer	en
dc.type	Article	en